RADX
Radiopharm Theranostics Limited
NASDAQ · Healthcare · Biotechnology · AU
$2.08
−3.48%Institutional positioning
13F filings over the trailing two quarters
New 0Increased 1Reduced 3Sold out 8
| Filer | Action | Shares | Filed |
|---|---|---|---|
| STONEPINE CAPITAL MANAGEMENT, LLC | Unchanged | 51,000,000 | May 14, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | Unchanged | 187,406 | May 14, 2026 |
| HSBC HOLDINGS PLC | Reduced | 61,372 | Apr 30, 2026 |
| REGAL PARTNERS LTD | Reduced | 40,138 | May 15, 2026 |
| PNC FINANCIAL SERVICES GROUP, INC. | Unchanged | 16,000 | May 8, 2026 |
| UBS GROUP AG | Reduced | 3,000 | May 5, 2026 |
| RHUMBLINE ADVISERS | Increased | 121 | May 12, 2026 |
| RHUMBLINE ADVISERS | Sold Out | 0 | May 12, 2026 |
| Stonepine Capital Management, LLC | Sold Out | 0 | May 14, 2026 |
| SILVERARC CAPITAL MANAGEMENT, LLC | Sold Out | 0 | May 14, 2026 |
| HSBC HOLDINGS PLC | Sold Out | 0 | Apr 30, 2026 |
| Regal Partners Ltd | Sold Out | 0 | May 15, 2026 |
| UBS Group AG | Sold Out | 0 | May 5, 2026 |
| STRATEGIC WEALTH PARTNERS, LTD. | Sold Out | 0 | May 12, 2026 |
| PNC FINANCIAL SERVICES GROUP, INC. | Sold Out | 0 | May 8, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings